A detailed history of Credit Suisse Ag transactions in Liva Nova PLC stock. As of the latest transaction made, Credit Suisse Ag holds 78,656 shares of LIVN stock, worth $3.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,656
Previous 76,878 2.31%
Holding current value
$3.78 Million
Previous $3.98 Million 10.64%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$48.6 - $57.12 $86,410 - $101,559
1,778 Added 2.31%
78,656 $4.4 Million
Q4 2023

Feb 08, 2024

BUY
$43.45 - $53.66 $331,262 - $409,103
7,624 Added 11.01%
76,878 $3.98 Million
Q3 2023

Nov 13, 2023

SELL
$50.12 - $58.87 $111,867 - $131,397
-2,232 Reduced 3.12%
69,254 $3.66 Million
Q2 2023

Aug 11, 2023

BUY
$42.28 - $51.43 $112,253 - $136,546
2,655 Added 3.86%
71,486 $3.68 Million
Q1 2023

May 10, 2023

BUY
$40.84 - $58.14 $218,534 - $311,107
5,351 Added 8.43%
68,831 $3 Million
Q4 2022

Feb 13, 2023

BUY
$43.88 - $56.16 $623,403 - $797,865
14,207 Added 28.83%
63,480 $3.53 Million
Q3 2022

Nov 10, 2022

BUY
$48.37 - $66.5 $33,133 - $45,552
685 Added 1.41%
49,273 $2.5 Million
Q2 2022

Aug 12, 2022

BUY
$57.25 - $86.63 $49,120 - $74,328
858 Added 1.8%
48,588 $3.04 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $52,057 - $63,763
733 Added 1.56%
47,730 $3.91 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $112,548 - $135,961
1,467 Added 3.22%
46,997 $4.11 Million
Q3 2021

Nov 12, 2021

BUY
$76.02 - $88.62 $269,490 - $314,157
3,545 Added 8.44%
45,530 $3.61 Million
Q1 2021

May 14, 2021

SELL
$62.9 - $82.41 $1.82 Million - $2.39 Million
-29,013 Reduced 40.86%
41,985 $3.1 Million
Q4 2020

Feb 12, 2021

BUY
$46.01 - $68.74 $1.37 Million - $2.05 Million
29,775 Added 72.23%
70,998 $4.7 Million
Q3 2020

Nov 13, 2020

SELL
$41.91 - $57.81 $201,251 - $277,603
-4,802 Reduced 10.43%
41,223 $1.86 Million
Q2 2020

Aug 12, 2020

BUY
$39.87 - $56.9 $285,150 - $406,948
7,152 Added 18.4%
46,025 $2.22 Million
Q1 2020

May 13, 2020

SELL
$34.22 - $76.49 $733,334 - $1.64 Million
-21,430 Reduced 35.54%
38,873 $1.76 Million
Q4 2019

Feb 12, 2020

BUY
$68.92 - $85.27 $481,268 - $595,440
6,983 Added 13.1%
60,303 $4.55 Million
Q3 2019

Nov 12, 2019

BUY
$71.74 - $86.35 $315,082 - $379,249
4,392 Added 8.98%
53,320 $3.93 Million
Q2 2019

Aug 14, 2019

SELL
$66.45 - $97.36 $798,263 - $1.17 Million
-12,013 Reduced 19.71%
48,928 $3.52 Million
Q1 2019

May 14, 2019

BUY
$86.15 - $100.49 $1.34 Million - $1.56 Million
15,507 Added 34.13%
60,941 $5.93 Million
Q4 2018

Feb 13, 2019

SELL
$84.14 - $125.42 $43,921 - $65,469
-522 Reduced 1.14%
45,434 $4.16 Million
Q3 2018

Nov 13, 2018

SELL
$101.02 - $130.95 $76,472 - $99,129
-757 Reduced 1.62%
45,956 $5.7 Million
Q2 2018

Aug 14, 2018

SELL
$81.75 - $105.37 $516,087 - $665,200
-6,313 Reduced 11.91%
46,713 $4.66 Million
Q1 2018

May 15, 2018

SELL
$79.95 - $89.74 $576,599 - $647,204
-7,212 Reduced 11.97%
53,026 $4.69 Million
Q4 2017

Feb 14, 2018

SELL
$71.8 - $88.21 $2.83 Million - $3.48 Million
-39,430 Reduced 39.56%
60,238 $4.81 Million
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $4.34 Million - $5.04 Million
72,009 Added 260.35%
99,668 $6.98 Million
Q2 2017

Aug 14, 2017

BUY
N/A
27,659
27,659 $1.69 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.57B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.